Zoono Group Past Earnings Performance
Past criteria checks 0/6
Zoono Group's earnings have been declining at an average annual rate of -32.2%, while the Chemicals industry saw earnings growing at 6.6% annually. Revenues have been declining at an average rate of 10.3% per year.
Key information
-32.2%
Earnings growth rate
-31.5%
EPS growth rate
| Chemicals Industry Growth | 14.4% |
| Revenue growth rate | -10.3% |
| Return on equity | -138.6% |
| Net Margin | -358.2% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Zoono Group (ASX:ZNO) Shareholders Will Want The ROCE Trajectory To Continue
Jun 19
Investors Will Want Zoono Group's (ASX:ZNO) Growth In ROCE To Persist
Mar 16Returns On Capital Are A Standout For Zoono Group (ASX:ZNO)
Sep 23Positive Sentiment Still Eludes Zoono Group Limited (ASX:ZNO) Following 27% Share Price Slump
Sep 02Calculating The Intrinsic Value Of Zoono Group Limited (ASX:ZNO)
Aug 31Zoono Group Limited (ASX:ZNO) Has Got What It Takes To Be An Attractive Dividend Stock
Mar 29We're Not So Sure You Should Rely on Zoono Group's (ASX:ZNO) Statutory Earnings
Feb 02What Kind Of Shareholders Hold The Majority In Zoono Group Limited's (ASX:ZNO) Shares?
Jan 11
Did You Miss Zoono Group's (ASX:ZNO) Impressive 235% Share Price Gain?
Dec 23How Should Investors React To Zoono Group's (ASX:ZNO) CEO Pay?
Dec 01How Much Are Zoono Group Limited (ASX:ZNO) Insiders Taking Off The Table?
Jul 27A Look At The Fair Value Of Zoono Group Limited (ASX:ZNO)
Jun 30Revenue & Expenses BreakdownBeta
How Zoono Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 2 | -8 | 5 | 0 |
| 30 Sep 23 | 3 | -4 | 6 | 0 |
| 30 Jun 23 | 3 | 0 | 7 | 0 |
| 31 Mar 23 | 4 | -4 | 8 | 0 |
| 31 Dec 22 | 5 | -8 | 9 | 0 |
| 30 Sep 22 | 7 | -10 | 10 | 0 |
| 30 Jun 22 | 9 | -11 | 11 | 0 |
| 31 Mar 22 | 14 | -5 | 10 | 0 |
| 31 Dec 21 | 19 | 1 | 10 | 0 |
| 30 Sep 21 | 23 | 3 | 10 | 0 |
| 30 Jun 21 | 27 | 5 | 9 | 0 |
| 31 Mar 21 | 39 | 12 | 9 | 0 |
| 31 Dec 20 | 51 | 19 | 10 | 0 |
| 30 Sep 20 | 45 | 18 | 8 | 0 |
| 30 Jun 20 | 38 | 17 | 6 | 0 |
| 31 Mar 20 | 21 | 7 | 4 | 0 |
| 31 Dec 19 | 3 | -2 | 3 | 0 |
| 30 Sep 19 | 2 | -2 | 3 | 0 |
| 30 Jun 19 | 2 | -2 | 3 | 0 |
| 31 Mar 19 | 1 | -2 | 3 | 0 |
| 31 Dec 18 | 1 | -2 | 3 | 0 |
| 30 Sep 18 | 2 | -1 | 3 | 0 |
| 30 Jun 18 | 2 | 0 | 2 | 0 |
| 31 Mar 18 | 3 | -1 | 2 | 0 |
| 31 Dec 17 | 3 | -2 | 2 | 0 |
| 30 Sep 17 | 2 | -3 | 2 | 0 |
| 30 Jun 17 | 1 | -4 | 3 | 0 |
| 30 Jun 16 | 1 | 0 | 1 | 0 |
Quality Earnings: ZNO is currently unprofitable.
Growing Profit Margin: ZNO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: ZNO is unprofitable, and losses have increased over the past 5 years at a rate of 32.2% per year.
Accelerating Growth: Unable to compare ZNO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: ZNO is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-53.6%).
Return on Equity
High ROE: ZNO has a negative Return on Equity (-138.62%), as it is currently unprofitable.